What does CAB stand for?

Conventional Amphotericin B (antifungal)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Comprehensive Ability Battery Compressed Application Binary Confederación Argentina de Basquetbol (Argentinian basketball league) Conference Advisory Board (various organizations) Conformity Assessment Body Congregation of Alexian Brothers Connectorized Active Bidirectional (coupler) Contract Adjustment Board Control Asking Bid (bridge game) Convenio Andrés Bello (Spanish)		Conversion a l'Agriculture Biologique Cooperative Analysis of Broadcasting Coordination Agro-Biologique (French: Agro-Biological Coordination) Coronary Artery Bypass Corporate Advisory Board Corporate Alliance Board (National Stroke Association) Corps And Below Corps Aviation Brigade Corrective Action Board Cost Analysis Brief

Samples in periodicals archive:

FDA stated that Abelcet is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.

Enzon Pharmaceuticals, Bridgewater, NJ, May 21 (Silver Spring, MD)

AmBisome has a demonstrated superior safety profile compared to conventional amphotericin B for the empirical treatment of febrile, neutropenic patients.

Data Show Efficacy of Standard Dosing Regimen of AmBisome(R) is ...

ABELCET is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.

Enzon to Launch CLEAR II Registry; New Initiative Reinforces ...

ABELCET is a lipid complex formulation of amphotericin B providing patients with significantly lower kidney toxicity than conventional amphotericin B.

Enzon Acquires Abelcet North American Business From Elan Transaction ...

Abelcet is a polyene antifungal agent indicated for serious invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.

Elan to Sell North American Rights to Abelcet for $370 Million in Cash

AmBisome has a demonstrated superior safety profile compared to conventional amphotericin B for the empirical treatment of febrile, neutropenic patients and in the treatment of cryptococcal meningitis.

Study Results Published in Journal of Clinical Infectious Diseases ...

Additionally, AmBisome is recommended for the treatment of patients where renal impairment or unacceptable toxicity suggests that conventional amphotericin B should not be used or should be discontinued.

Gilead Announces Data Demonstrating That Single Dose of Ambisome ...

Pharmacoeconomic Study Compares Total Hospital Costs of AmBisome to ...